Central. Discover Endless Oncology Nursing CE Opportunities! ONCOLOGY EDUCATION SERVICES, INC. PRINT-BASED SPEAKER BUREAUS TELECONFERENCES

Transcription

1 CESpring 2004 Central SPEAKER BUREAUS TELECONFERENCES ONCOLOGY EDUCATION SERVICES, INC. Discover Endless Oncology Nursing CE Opportunities!

2 Monographs Print-based continuing education programs, or monographs, are publications containing information that can be reviewed at a self-directed pace. OES offers several monographs that can be ordered or downloaded (when available) free via our website at by fax (form at end of catalogue) to , or by calling Expanding Applications of Colony-Stimulating Factors: A Case Study Approach 2.1 Contact Hours CE ID: 2651 Expires: 04/23/06 This monograph addresses the potential clinical uses of colony stimulating factors beyond neutrophil recovery. Among the applications of GM-CSF which are explored are: it use in wound healing, Crohn s disease, and mucositis; its utility and role in managing malignant melanoma; its use in Cytokine Therapy: The GM & D Factor (GM&D) 1.9 Contact Hours CE ID: 2144 Expires: 10/22/04 Appropriate for oncology nurses with a general understanding of dendritic cells and cytokines as a treatment for cancer. Strongly recommend reading DC and CSF programs prior to this piece. Discusses the infection-fighting potential of cytokines Discusses dendritic cells role in cancer treatment Discusses synergy between cytokines and monoclonal antibody therapy for cancer treatment Discusses the importance of cell cycling in cancer treatment Dendritic Cells: The Sentry Cells of the Hematopoietic Cell Line (DC) 1.6 Contact Hours CE ID: 2283 Expires: 5/1/05 combination with thalidomide in prostate cancer; its role in 2 the development of dendritic cell vaccines; and its efficacy 3 in maintaining dose-dense chemotherapy. Discusses dendritic cell function in the immune system Discusses the use of dendritic cells in cancer treatment Provides a comprehensive, easy-to-read overview of the immune system Chemotherapy-Induced Nausea and Vomiting: The Past, the Present, and the Future 1.8 Contact Hours CE ID: 2424 Expires: 09/25/05 Sponsored by an unrestricted educational grant from Merck & Co. Inc. Discusses past treatment issues related to CINV Describes consensus guidelines for the treatment CINV Explains the role of NK1 antagonists in CINV Discovering the Options: Hematopoietic Growth Factors and the Oncology Patient 1.0 Contact Hours CE ID: 2059 Expires: 8/14/04 The Continuum of Cachexia: Timing Your Interventions 1.3 Contact Hours CE ID: 2250 Expires: 2/10/05 Sponsored by an educational grant from Solvay Pharmaceuticals. Cancer-related cachexia interventions and effective timing for those interventions Neutropenia: Risk Factors and Management Anemia: Risk Factors and Management Novel Hematopoietic Growth Factors

3 The Journey to Patient Empowerment: Combining Patient Goals of Therapy with Treatment Options in Non-Small Cell Lung Cancer 2.2 Contact Hours CE ID: 2451 Expires 09/24/05 Sponsored by an educational grant from Lilly Oncology. Discusses issues and future trends related to the treatment of non-small cell lung cancer Describes ways to empower patients to become partners in the management of their disease Summarizes how a patient can communicate his or her needs with regard to treatment options Targeted Therapy Newsletter Series This newsletter series discusses molecular and targeted therapy options in cancer care. Novel Therapies Deserve Novel Educational Approaches: Teaching Peers and Patients About Monoclonal Antibodies 1.1 Contact Hours CE ID: 2141 Expires: 10/22/04 Sponsored by an educational grant from Genentech BioOncology & IDEC Pharmaceuticals Corporation. Appropriate for all oncology nurses caring for patients receiving monoclonal antibody therapy. A unique monograph aimed at providing comprehensive information about monoclonal antibodies as well as providing analogies and strategies to aid oncology nurses efforts to teach patients and other healthcare professionals about monoclonal antibodies Discusses different types of monoclonal antibodies Discusses the difference between monoclonal antibody therapy and chemotherapy Provides suggestions to effectively communicate complex information to patients and peers Volume 1, Issue 1 Fall 2003 Molecular and Targeted Therapies in Cancer Care: From Concept to Chairside 4 Nursing Considerations for the Treatment Contact Hours CE ID: 2468 Expires: 10/24/05 of Late-Stage Multiple Myeloma Sponsored by an educational grant from Genentech BioOncology. 2.9 Contact Hours CE ID: 2346 Expires: 7/1/05 This newsletter is the first in a series that will provide information to assist healthcare providers in understanding the role of molecular and targeted therapy treatment options. The pathophysiology of cancer will be reviewed in addition to exploring various treatment options, mechanisms of action, and strategies for side effect management from a nursing perspective. Sponsored by an educational grant from Cell Therapeutics, Inc. Multiple myeloma late-stage therapy treatment options, symptom management strategies, and novel therapies Volume 1, Issue 2 Spring 2004 Targeting Colorectal Cancer: Novel Approaches to Patient Care 1.3 Contact Hours CE ID: 2615 Expires: 4/12/06 Sponsored by an educational grant from Genentech BioOncology. This newsletter is the second in the series on molecular and targeted therapy treatment options. In this issue, the epidemiology and mechanisms of metastatic colorectal cancer (MCRC) are explored. In addition, agents that target vascular endothelial growth factor (VEGF) and endothelial growth factor receptor (EGFR) are examined as therapies in MCRC because of their unique role in preventing angiogenesis. Nursing Considerations for the Treatment of Myelodysplastic Syndromes 1.5 Contact Hours CE ID: 2347 Expires: 7/1/05 Sponsored by an educational grant from Cell Therapeutics, Inc. Myelodysplastic syndrome (MDS) treatment options and symptom management strategies Implications each treatment has on the patient and the nurse providing patient care

4 Oncology Supportive Care Quarterly (OSCQ) This quarterly publication addresses cutting-edge topics oncology nurses face daily in the supportive care arena. Volume 1, Issue 1: Ambulatory Setting 1.5 Contact Hours CE ID: 2037 Expires: 6/20/04 Pertinent information for nurses that can be useful in providing supportive care to patients in the ambulatory setting - Psychosocial - Management of Anemia - Management of Neutropenia - Telephone Triage Volume 1, Issue 4: Quality of Life 3.0 Contact Hours CE ID: 2301 Expires: 4/29/05 Symptoms that affect quality of life in patients with cancer and strategies to manage deleterious symptoms to enhance quality of life - Effects of Neutropenia - Impact of Cancer-Related Anemia - Impact of Mucositis - Nausea & Vomiting: Palliation Volume 2, Issue 1: Elderly Care 2.8 Contact Hours CE ID: 2363 Expires: 8/26/05 Appropriate for all oncology nurses who care Volume 1, Issue 2: Nursing Education for the elderly adult with cancer. Key Facts 1.4 Contact Hours CE ID: 2149 Expires: 11/21/04 Decline of Bone Marrow Function Geriatric Assessment 6 Supportive Care 7 Professional nursing education and learning - Chemotherapy-Induced Anemia and Chemotherapy- Induced Neutropenia: The Impact on Cancer Care - Creative and Effective Ways to Teach - Oncology Education Online Volume 1, Issue 3: Myelosuppression 1.4 Contact Hours CE ID: 2181 Expires: 2/17/05 Causes of myelosuppression, models used for preventive care, and use of HGFs for prevention - Myelosuppression Related to Treatment - High Risk Populations - HGF Combinations - Biologic Agents and Fluid Retention Volume 2, Issue 2: Dose Density 2.2 Contact Hours CE ID: 2474 Expires: 12/15/05 Overview of the use of dose-dense chemotherapy regimens - Dose-Dense Chemotherapy - Breast Cancer Dose-Dense Treatment - NHL Dose-Dense Treatment - Dose-Dense Regimens and the Elderly Volume 2, Issue 3: Treatment Modalities 1.9 Contact Hours CE ID: 2616 Expires: 04/01/06 Appropriate for all oncology nurses Overview of the different treatment modalities - Surgery - Bone Marrow Transplant - Radiation Therapy

5 Rethinking Platelet Growth Factors A series of 3 newsletters All 3 newsletters discuss methods to improve patient assessment and, thus, identification of patients who may benefit from hematopoietic growth factors to reduce dose delays during chemotherapy. Volume I: Planned Dose on Time: The Danger of Treatment Delays 1.0 Contact Hours CE ID: 2110 Expires: 10/22/04 Sponsored by an educational grant from Wyeth Oncology. Discusses significant differences between using growth factors for rescue versus early intervention Defines dose intensity and its relationship to patient outcomes Discusses complications due to thrombocytopenia seen as a side effect of cancer therapy Discusses use of platelet growth factors in maintaining planned doses of chemotherapy on time Totally New Totally Clinical: Interactive Case Studies on Nursing Management of Cancer-Related Anemia and Neutropenia 1.7 Contact Hours CE ID: 2249 Expires: 2/10/05 Appropriate for advanced-practice oncology nurses. Proactive nursing management of cancer-related anemia and neutropenia OES print-based CE programs have been approved by the Oncology Nursing Society's (ONS) Approver Unit for contact hours. The ONS is accredited as an approver of CE in nursing by the American Nurses Credentialing Center's Commission on Accreditation. ONS's approval of CE credit for these learning programs does not imply endorsement of the sponsor, nor does ONS assume responsibility for the educational content of these programs. Speaker Bureaus Volume II: Evidence-Based Medicine OES manages several speaker bureaus offering high-quality education for nurses of all levels and disciplines. Our speakers come from 1.0 Contact Hours CE ID: 2145 Expires: 11/8/ a talented pool of nationally-recognized oncology nursing experts. Sponsored by an educational grant from Wyeth Oncology. Available topics: Breast Cancer B-Cell Disorders Colorectal Cancer Non-Hodgkin s Lymphoma Discusses the role of oncology nurses with regard to novel therapies in cancer treatment Can we bring a program to you? Discusses mindful practice Let OES plan all the details for you. OES will bring the speaker, the Discusses effective communication patterns for patients program, and the learning to you. All you have to do is sit back and and family education enjoy. For more information, please contact OES by at oes@ons.org or call toll-free at Volume III: Dose Reductions and Delays of Chemotherapy in the Clinical Setting 1.0 Contact Hours CE ID: 2332 Expires: 7/1/05 Sponsored by an educational grant from Wyeth Oncology. This program will provide an overview of evidence-based practice and mindful practice as they relate to platelet growth factors and other new cancer therapies Explain the evidence-based practice of dose reductions and delays due to low blood counts Use the appropriate growth factors in the management of myelosuppression Discuss the nurse s role in patient advocacy and education related to dose reductions and delays SPEAKER BUREAUS A Targeted Approach to Colorectal Cancer Management: The Role of the Healthcare Professional Regional Nurse Advocate Programs Contact Hours: 1.2 CE ID: 2480 Expires: 11/13/05 Sponsored by an educational grant from Genentech BioOncology. Appropriate for nurses, pharmacists, and other health care providers. Participants will be able to: Define the rationale for targeting VEGF and angiogenesis in treating colorectal cancer Differentiate between targeting EFGR and VEGF in treating colorectal cancer Identify symptom management strategies for anti-vegf therapy in colorectal cancer

6 Teleconferences OES understands the need for flexibility and variable options for continuing education programs. We understand adult learning principles and the need to make the learning process as convenient as possible during today's busy lifestyle. Teleconferences allow nurses to participate in an activity at a convenient time, while maintaining the interactivity of the live program. New teleconferences are added frequently. To find out about all available teleconferences visit us on the web at TELECONFERENCES FREE Teleconference Series Clinical Forums in Oncology Nursing 2004 Presented by Oncology Nurse Practice Consultants (ONPCs) MAY 2004 Radioprotection in Head and Neck Cancer Discuss the implications of side effects occurring in patients receiving radiation therapy Discuss the mechanism of action of Ethyol in radioprotection Synthesize plans of care for preventing and managing side effects related to administration of Ethyol Date: Monday, May 10, 2004 Time: 12:00 PM EST Call-in #: ID: Presenter: Maryann Dzibela, RNC, MSN, OCN, CCRP TELECONFERENCES July 2004 Symptom Management Peripheral Neuropathy Define Peripheral Neuropathy Describe clinical sequelae of chemotherapy induced neuropathy. Review the mechanism of action of Ethyol as a cytoprotectant. Identify appropriate nursing interventions pre/post Ethyol administration. Date: Wednesday, July 13, 2004 Time: 6:00 PM PST Call-in #: ID: Presenter: Heather Vanderploeg, RN, OCN For more information on registering for the Clinical Forums Teleconference Series, please visit us on the web at or call ext OES live CE programs have been approved by the Oncology Nursing Society's (ONS) Approver Unit for contact hours. The ONS is accredited as an approver of CE in nursing by the American Nurses Credentialing Center's Commission on Accreditation. ONS's approval of CE credit for these learning programs does not imply endorsement of the sponsor, nor does ONS assume responsibility for the educational content of these programs A Tree is Known by its Fruit. JUNE 2004 Myelodysplastic Syndromes in the Oncology Patient Describe classification systems for Myelodysplastic Syndromes. Identify current treatment modalities for Myelodysplastic Syndromes. Review the mechanism of action of Ethyol as a cytoprotectant. Identify appropriate nursing interventions pre/post Ethyol administration. Date: Wednesday, June 9, 2004 Time: 1:00 PM EST Call-in #: ID: Presenter: Annette Quinn, MSN, RN At OES, the fruit of our efforts comes from providing the very best CE opportunities for nurses involved in the ever-changing world of oncology care. But, the most satisfaction comes as those nurses share their knowledge with compassion, respect, and integrity through the most difficult circumstances. We are thankful to play a part in that.

7 Web-Based Cytokine Therapy: The GM&D Factor Web-based continuing education has seen tremendous growth in recent years. OES understands the value of FREE web-based nursing CE.We have planned and developed several web-based programs, which enable nurses to flexibly access cutting-edge programs 24 hours a day and 7 days week. Additionally, nurses can earn contact hours instantly at their convenience. OES s webbased credits also include CD-ROM programs. Visit us on the web at to access all of our web-based continuing education opportunities. Are Oncology Nurses the Strongest Link? Effective Management of Chemotherapy-Associated Neuropathy, Anemia, and Neutropenia 1.4 Contact Hours CE ID: 2179 Expires 2/10/05 Sponsored by an educational grant from Solvay Pharmaceuticals, Inc. Cancer-related cachexia interventions and effective timing for those interventions 2.0 Contact Hours CE ID: 2196 Expires 3/05/05 Appropriate for oncology nurses with a general understanding of dendritic cells and cytokines as a treatment for cancer. Strongly recommend completing DC and CSF programs prior to this piece. Discusses the infection-fighting potential of cytokines Discusses dendritic cells' role in cancer treatment Discusses synergy between cytokines and monoclonal antibody therapy for cancer treatment Discusses the importance of cell cycling in cancer treatment 1.8 Contact Hours CE ID: 2377 Expires 8/27/05 Dendritic Cells: The Sentry Cells of the Immune System 1.6 Contact Hours CE ID: 2284 Expires 5/1/ This is an interactive continuing education program that provides nurses with knowledge regarding management of 13 patients with neuropathy, anemia, and neutropenia. Discusses dendritic cell function in the immune system Discusses the use of dendritic cells in cancer treatment The Continuum of Cachexia: Timing Your Intervention Provides a comprehensive, easy-to-read overview of the immune system CHECK OUT OUR NEW WEBSITE! Instant access to education at Education for Patients with Metastases to Bone 1.8 Contact Hours CE ID: 2386 Expires 08/06/05 Sponsored by an educational grant from Novartis Oncology. Patient education and communication on causes and treatment of bone metastases

8 The Future is Now: Therapeutic Options for Chemotherapy-Induced Nausea and Vomiting 1.5 Contact Hours CE ID: 2032 Expires 10/01/05 Sponsored by an unrestricted educational grant from Merck & Co., Inc. Discusses professional perceptions of CINV control Identifies strategies the oncology nurse can use to encourage and facilitate practice change Discusses the neuro-pharmacology of emesis Describes aprepitant, a new form of targeted treatment option for CINV Patient Empowerment: Combining Patient Goals of Therapy With Treatment Options in Metastatic Breast Cancer 1.5 Contact Hours CE ID: 2049 Expires 07/23/04 Sponsored by an educational grant from Lilly Oncology. Discusses ways to empower patients to become partners in the management of their disease Summarizes how a patient can communicate their needs related to treatment options Explains treatment issues and future trends related to metastatic breast cancer Impacting Patient Outcomes: Chemotherapy-Induced Nausea & Vomiting 1.2 Contact Hours CE ID: 2416 Expires: 9/30/2005 Patient Empowerment: Combining Patient Goals of Therapy With Treatment Options in Non-Small Cell Lung Cancer (NSCLC) Sponsored by an unrestricted educational grant 2.2 Contact Hours CE ID: 2451 Expires 8/22/05 from Merck & Co., Inc. Sponsored by an educational grant from Lilly Oncology Appropriate for oncology nurses interested in evidencedbased data supporting management chemotherapy-induced nausea and vomiting. Debra Wujcik, RN, MSN, AOCN, will discuss symptom management strategies for patients with chemotherapyinduced nausea and vomiting. Nutrition Interventions to Impact Clinical Practice 2.1 Contact Hours CE ID: 2372 Expires: 9/01/05 Sponsored by an educational grant from Novartis Nutrition Corporation. Appropriate for oncology nurses, dietitians, and pharmacists. Effective assessment and treatment strategies in nutrition and cancer - Cancer Treatment and Nutrition - Starvation and Cachexia - Nutritional Assessment - Plan of Care Discusses issues and future trends related to the treatment of non-small cell lung cancer Describes ways to empower patients to become partners in the management of their disease Summarizes how a patient can communicate his or her needs with regard to treatment options Radioimmunotherapy for Indolent Non-Hodgkin s Lymphoma: Rationale, Safety, Efficacy, and Practical Issues 2.2 Contact Hours CE ID: NEED Expires 07/11/04 Sponsored by an educational grant from Lymphoma Research Foundation and IDEC Pharmaceuticals. Appropriate for nurses, certified oncology nurse professionals, and nursing students. This symposium has been designed to teach about radioimmunotherapy and its potential benefits for patients with non-hodgkin's lymphoma.

9 Timing & Effect: Dendritic Cells and Cell Cycling in Cancer Treatment Outcomes 3.1 Contact Hours CE ID: 2381 Expires 09/30/05 This program is intended for oncology nurses interested in learning about dendritic cells and cell cycling in regard to the immune system and cancer therapy. The nursing implications of therapies employing dendritic cells and affecting cell cycling are explored. COMING SOON! Don t Miss These Other CE Opportunities! Totally New Totally Clinical 1.4 Contact Hours CE ID: 2178 Expires 2/10/05 This program reviews proactive nursing management of cancer-related anemia and neutropenia. On Target: Molecular Targets In Oncology Care This program will discuss targeted therapy treatment options, both as single agents and in combination with other treatment options, including: Summarize roles of HER1/EGFR and VEGF activity in cancer. Identify patients most likely to respond to above therapies. Discuss rationale for combination of these therapies. Discuss symptom management and patient education specific to these therapies. Effective Use of Hematopoietic Growth Factors: A Focus on Thrombocytopenia 1.2 Contact Hours 16 Management of Patients With High-Risk-for-Relapse Prostate Cancer 1.2 Contact Hours CE ID: 2527 Expires: 01/06/06 Sponsored by an educational grant from AstraZeneca Urology. This webcast is appropriate for oncology and urology nurses seeking information to improve their skills in caring for patients with high-risk-for-relapse prostate cancer. This webcast will enable participants to: Discuss the physiology of prostate cancer Discuss the management of the patient with high-riskfor-relapse prostate cancer. Summarize the nursing care issues in the management of the patient with high-risk-for-relapse prostate cancer Explain the role of hormonal therapy in high-risk-forrelapse prostate cancer Sponsored by an educational grant from Wyeth Oncology. This program will give oncology nurses the information they need to positively affect treatment outcomes by using growth factors to maintain planned dose on time. It is intended for oncology nurses seeking information to improve their skills in assessing and identifying patients who can benefit from hematopoietic growth factors to reduce dose delays during chemotherapy. 17 OES web-based CE programs have been approved by the Oncology Nursing Society's (ONS) Approver Unit for contact hours. The ONS is accredited as an approver of CE in nursing by the American Nurses Credentialing Center's Commission on Accreditation. ONS's approval of CE credit for these learning programs does not imply endorsement of the sponsor, nor does ONS assume responsibility for the educational content of these programs. PATIENT EDUCATION OTHER ONCOLOGY RELATED TOOLS Right on Time: Your Chemotherapy Success - The right dose at the right time can make a difference This patient education booklet focuses on timing, understanding, and gaining control. It addresses the impact of dose delays/reductions on chemotherapy treatment success. This booklet also explains blood counts and growth factors, and it provides helpful advice to the patient who wants to become a more active participant in his/her treatment decisions.

10 ONCOLOGY EDUCATION SERVICES, INC. For faster service, order your monographs online at Or, fill out this form and fax to: Please allow 10 days for processing. MONOGRAPH ORDER FORM Name: Address: 18 Our History Oncology Education Services (OES), Inc. was incorporated as a subsidiary of the Oncology Nursing Society (ONS) in December OES has become a full-service medical education company focusing on a variety of oncologyspecific programs and services for health care professionals, specifically oncology nurses. Our Vision To be the premier oncology-related educational services corporation. Our Mission To market quality oncology-related programs, products, and services that subscribe to the inter-organizational core values. What OES Provides Nurses As a subsidiary of ONS, we have an intimate knowledge of what oncology nurses need and face on a daily basis. OES is a leader in providing FREE continuing education (CE) products to oncology professionals in a variety of formats including publications, speaker bureau programs,webbased courses, and teleconferences. OES offers the most current, cutting-edge programs available. To learn more, visit us on the web at for the newest continuing education curriculum in oncology. Our Team OES is comprised of talented professionals in nursing, meeting planning, management, and marketing, including highly experienced project managers, and is managed by individuals with direct oncology nursing experience Nurses know what nurses need. City: State: Zip: Phone: Fax: ONS Member #: Note: By providing your & fax, you are granting permission to ONS and its subsidiaries to communicate with you via fax or . ONS will not share or fax information with outside entities. Please send me the following monographs: CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients --Volume 1, Issue 1: Ambulatory Setting CE ID: Discovering the Options: Hematopoietic Growth Factors and the Oncology Patient CE ID: Rethinking Platelet Growth Factors Volume I: Planned Dose on Time: The Danger of Treatment Delays CE ID: Novel Therapies Deserve Novel Educational Approaches: Teaching Peers and Patients About Monoclonal Antibodies CE ID: Cytokine Therapy: The GM & D Factor (GM&D) CE ID: Rethinking Platelet Growth Factors Volume II: Evidence Based Medicine CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients--Volume 1, Issue 2: Nursing Education CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients--Volume 1, Issue 3: Myelosuppression CE ID: Totally New Totally Clinical: Interactive Case Studies on Nursing Management of Cancer-Related Anemia and Neutropenia CE ID: The Continuum of Cachexia: Timing Your Interventions CE ID: Dendritic Cells: The Sentry Cells of the Hematopoietic Cell Line (DC) CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients--Volume 1, Issue 4: Quality of Life CE ID: Rethinking Platelet Growth Factors -- Volume III: Dose Reductions and Delays of Chemotherapy in the Clinical Setting CE ID: Nursing Considerations for the Treatment of Late-Stage Multiple Myeloma CE ID: Nursing Considerations for the Treatment of Myelodysplastic Syndromes CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients--Volume 2 Issue 1: Elderly Care CE ID: Chemotherapy-Induced Nausea and Vomiting: The Past, the Present, and the Future CE ID: The Journey to Patient Empowerment: Combining Patient Goals of Therapy with Treatment Options in Non-Small Cell Lung Cancer CE ID: Molecular and Targeted Therapies in Cancer Care: From Concept to Chairside CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients--Volume 2, Issue 2: Dose Density CE ID: Targeting Colorectal Cancer: Novel Approaches to Patient Care CE ID: Oncology Supportive Care Quarterly: Focused on Nursing Issues in the Care of Oncology Patients -- Volume 2, Issue 3: Treatment Modalities CE ID: Expanding Applications of Colony-Stimulating Factors: A Case Study Approach 19

11 A subsidiary of the Oncology Nursing Society Oncology Education Services, Inc. 125 Enterprise Drive Pittsburgh, PA FIRST CLASS U.S. POSTAGE PAID PITTSBURGH, PA PERMIT #1715 Don t Miss The Newest CE Opportunities! We aim to deliver the most current continuing education programs available to oncology nurses. Please check our website frequently for our recently approved oncology nursing programs.